These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30559024)

  • 21. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.
    Fermin CR; Lee AM; Filipp SL; Gurka MJ; DeBoer MD
    Metab Syndr Relat Disord; 2017 Aug; 15(6):276-282. PubMed ID: 28520503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Real-World Electronic Health Record Data to Assess Chronic Disease Screening in Children: A Case Study of Non-Alcoholic Fatty Liver Disease.
    Kraus EM; Pierce SL; Porter R; Kompaniyets L; Vos MB; Blanck HM; King RJ; Goodman AB
    Child Obes; 2024 Jan; 20(1):41-47. PubMed ID: 36862137
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
    Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.
    Schwimmer JB; Dunn W; Norman GJ; Pardee PE; Middleton MS; Kerkar N; Sirlin CB
    Gastroenterology; 2010 Apr; 138(4):1357-64, 1364.e1-2. PubMed ID: 20064512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents.
    Wiegand S; Keller KM; Röbl M; L'Allemand D; Reinehr T; Widhalm K; Holl RW;
    Int J Obes (Lond); 2010 Oct; 34(10):1468-74. PubMed ID: 20531349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014.
    Kim JW; Lee KJ; Yang HR; Chang JY; Moon JS; Khang YH; Ko JS
    BMC Public Health; 2018 May; 18(1):617. PubMed ID: 29751750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simpler diagnostic formula for screening nonalcoholic fatty liver disease.
    Feng G; He N; Zhou YF; Li XP; Niu C; Liu ML; Zhang KL; Li Y; Li YM; Zheng MH; Mi M
    Clin Biochem; 2019 Feb; 64():18-23. PubMed ID: 30503530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic fatty liver disease prevalence in urban school-aged children and adolescents from the Yangtze River delta region: a cross-sectional study.
    Zhang X; Wan Y; Zhang S; Lu L; Chen Z; Liu H; Jiang X; Luo K; Cai W
    Asia Pac J Clin Nutr; 2015; 24(2):281-8. PubMed ID: 26078245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.
    Molleston JP; Schwimmer JB; Yates KP; Murray KF; Cummings OW; Lavine JE; Brunt EM; Scheimann AO; Unalp-Arida A;
    J Pediatr; 2014 Apr; 164(4):707-713.e3. PubMed ID: 24360992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.